This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers, including Justin Balko, PhD, PharmD, reported April 22 in the journal Science Translational Medicine.
The findings were reported March 19 in the Nature partner journal npj Breast Cancer; the paper’s corresponding author is Sonya Reid, MD, MPH, associate professor of Medicine at Vanderbilt Health.
Mohamed Shanshal, MD, and Fabien Maldonado, MD, faculty members in the Department of Medicine, were integral members of the treatment team.
Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person’s natural defense system against tumors.
Hematologists with Vanderbilt-Ingram Cancer Center have published strategies for implementing outpatient treatment programs for bispecific antibodies, an immunotherapy that can cause adverse reactions.
Ben Ho Park, MD, PhD, Professor of Medicine (Hematology and Oncology) and Director of the Vanderbilt-Ingram Cancer Center, was recently announced as the recipient of the American Association for Cancer Research's 2025 Distinguished Lectureship in Breast Cancer Research award.
Jennifer Lewis, MD, Assistant Professor of Medicine, and colleague Lucy Spalluto, MD (Radiology and Radiological Sciences), were recently awarded a $1 million grant from AstraZeneca to understand and improve veteran access to mobile lung cancer screening.
VUMC recently held a Directorship Celebration to honor 23 leaders, including seven in the Department of Medicine, from across the enterprise in clinical care, research, education and administration.
